Publication Date:
2018-02-21
Description:
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia, Published online: 20 February 2018; doi:10.1038/s41467-018-03170-7 BCL2-inhibitor venetoclax is used to treat relapsed/refractory chronic lymphocytic leukemia (CLL). Here, the authors show the clonal dynamics towards venetoclax resistance by performing whole-exome sequencing of 8 CLL patients undergoing venetoclax treatment.
Electronic ISSN:
2041-1723
Topics:
Biology
,
Chemistry and Pharmacology
,
Natural Sciences in General
,
Physics
Permalink